Clinician Strategies and Resources: Caring for AYAs as they Transition to Cancer Survivorship (Participant)

Credit Available: ASWB, CME, CABRN, NP

 

Enroll in this Course

FREE

access until June 17, 2025 12:00 am

 

Enroll Now

Activity Description

This webinar, featuring a panel of subject matter experts, addresses the unique challenges faced by adolescents and young adults (AYAs) with cancer as they transition into survivorship, emphasizing interdisciplinary care and long-term support. Resources to support AYAs, their caregivers, and healthcare professionals will also be provided.

Time to Complete Activity: 1 hour

This course is available from:

June 18, 2024 until June 17, 2025

Course Instructors

Rebecca Eary, DO, MPH Speaker

Assistant Professor, Department of Family and Community Medicine, UT Southwestern Medical School, Medical Director, Primary Care Cancer Survivorship Clinic and the After Cancer Experience (ACE), Adult Program for Adolescent and Childhood Cancer Survivors, Dallas, TX

Danielle Friedman, MD, MS Speaker

Associate Member, Department of Pediatrics, MSK Kids, Director, Pediatric Long-Term Follow-Up Program, Director, Pediatric Survivorship Fellowship, Memorial Sloan Kettering Cancer Center, New York, NY

Brittany Hall, PhD Speaker

Associate Professor, UT Southwestern Medical Center Dallas, TX

Michelle Rajotte, LMSW Moderator

Associate Director, Information Resource Center, The Leukemia & Lymphoma Society, Rye Brook, NY

Michael Roth, MD Speaker

Professor of Pediatrics, Medical Director, Cancer Survivorship, Co-Director, Adolescent and Young Adult Oncology Program, Director, Childhood Cancer Survivorship Program, University of Texas M.D. Anderson Cancer Center, Chair, Children’s Oncology Group AYA Oncology, Discipline Committee, Houston, TX

Angela Yarbrough, DNP, APRN, FNP-BC, CPHON Speaker

Nurse Practitioner, University of Texas M.D. Anderson Cancer Center, Houston, TX

Target Audience

This activity is intended for hematologist/oncologists, APPs, nurses, social workers, and other healthcare professionals involved in the care of adolescent and young adult (AYA) patients with cancer and cancer survivors. 

Educational Objectives

After completing this activity, the participant should be better able to:

• • Describe care challenges for AYAs as they transition to survivorship
  • Explain the importance of survivorship care, including late effects and how to access long-term follow-up guidelines
  • Identify interdisciplinary care team roles in supporting AYA cancer survivors
  • Review resources to support AYAs with cancer, their caregivers, and healthcare professionals

Accreditation, Support and Credit

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Practitioner Continuing Education 

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 24076719. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Registered Nursing Credit Designation

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Social Worker Continuing Education

As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 Clinical Social Work continuing education credit.

Interprofessional Continuing Education Credit

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Providers

 

This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc., in collaboration with The American Cancer Society.

Support Statement

There is no commercial support associated with this CE activity.

Disclosure of Conflicts of Interest Policy

Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society, are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, MLI and LLS require faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI and LLS policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Rebecca Eary, DO, MPH, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Danielle Friedman, MD, MS, has no relevant financial relationships with ineligible companies to disclose for this educational activity. 

Brittany Hall, PhD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Michelle Rajotte, LMSW, has no relevant financial relationships with ineligible companies to disclose for this educational activity. 

Michael Roth, MD, has a financial interest/relationship or affiliation in the form of:
Research Grant: Pfizer, HebeCell

Angela Yarbrough, DNP, APRN, FNP-BC, CPHON, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

Lauren Berger, MPH, has a financial interest/relationship or affiliation in the form of:
Stock Ownership with Bristol Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc., Organon & Co., Pfizer Inc., and Viatris Inc.

All of the relevant financial relationships of individuals for this activity have been mitigated.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

About this Activity

Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. 

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. 

If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@mlieducation.org.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.